Emile Mehanna, MD, FACC

Professional Bio:

Dr Mehanna is a board certified interventional cardiologist and vascular specialist. He is a clinical assistant professor of cardiology and the cardiovascular fellowship training program director at the Lebanese American University (LAU) Medical school and center. Soon after his graduation from the American University of Beirut Medical School in 2009, Dr Mehanna moved to Cleveland, Ohio where he completed a research fellowship in invasive imaging at the cardiovascular imaging core laboratory of the Case Western Reserve University (2009-2011), followed by a residency in internal medicine (2011-2014) and a fellowship in cardiology (2014-2017). He then joined Brown University for his interventional cardiology fellowship (2017-2018) before pursuing a vascular medicine and intervention fellowship at the Massachusetts General Hospital and the Harvard Medical School in Boston (2018-2019). He is certified by the American board of Internal Medicine, Cardiology and Interventional Cardiology. He is a Fellow of the American College of Cardiology (FACC) and the Society for Cardiovascular Angiography and Interventions (FSCAI). He has won numerous awards and distinctions including the resident and fellow research awards of the Case Western Reserve University School of Medicine Department of Medicine for his work on three dimensional atherosclerotic plaque assessment, the Fellow of the Year Award at University Hospitals Case Medical Center and the Louis Stokes VA Medical Center, Cleveland. Emile has authored over 25 peer-reviewed articles, 5 book chapters and is a reviewer for several scientific journals. His research focus is on the development of modern percutaneous coronary interventional techniques, notably the use of intravascular imaging, specifically optical coherence tomography for the diagnosis and treatment of coronary and vascular disease.

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Abbott Laboratories(SIGNIFICANT), Boston Scientific(MODEST) SPEAKER'S BUREAU: CSI(MODEST)

View Full Disclosure